IPSC PEER ANALYSIS

Century Therapeutics Inc — metric-by-metric comparison with peers and the industry median

IPSCCentury Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

IPSCIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	IPSC	RTALB	MSB	TLX	Ind. Median
P/E	—	4.89	—	—	17.81
P/B	0.78	0.61●	—	6.56	3.49
EV/EBITDA	—	74.61●	—	123.31	14.92
P/S	—	6.67	31.91	3.34●	10.89

Financial Health
Metric	IPSC	RTALB	MSB	TLX	Ind. Median
Current Ratio	10.25●	1.21	—	1.43	5.90
Debt/Equity	18.1%	1.2%●	—	112.3%	10.9%
NetDebt/EBITDA	0.97	0.90●	—	13.13	1.15

Profitability
Metric	IPSC	RTALB	MSB	TLX	Ind. Median
Net Margin	—	136.3%●	-115.3%	-0.9%	-125.7%
ROE	-42.7%	15.1%●	-11.3%	-1.8%	-47.5%
ROA	-33.6%	13.1%●	-8.6%	-0.7%	-35.8%
EBITDA Margin	—	9.0%●	-76.6%	3.0%	-105.8%

Growth + Dividend
Metric	IPSC	RTALB	MSB	TLX	Ind. Median
Rev. Growth	-100.0%	24.0%	410.4%●	56.3%	5.1%
NI Growth	—	134.0%	—	—	12.1%
Div. Yield	—	0.0%●	0.0%●	—	0.2%
Payout	—	0.0%	0.0%	—	0.0%

Valuation
Metric	IPSC	ARCT	NAUT	OVID	CHRS	CDXS	Ind. Median
P/E	—	—	—	—	—	—	17.81
P/B	0.78●	1.09	1.51	0.97	2.71	5.58	3.49
EV/EBITDA	—	—	—	—	—	—	14.92
P/S	—	4.61	—	27.02	4.54	3.09●	10.89

Financial Health
Metric	IPSC	ARCT	NAUT	OVID	CHRS	CDXS	Ind. Median
Current Ratio	10.25	6.31	11.85●	10.17	1.56	5.36	5.90
Debt/Equity	18.1%	12.5%	20.0%	0.7%●	69.2%	168.6%	10.9%
NetDebt/EBITDA	0.97	2.78	1.32	6.42	0.70	-0.33●	1.15

Profitability
Metric	IPSC	ARCT	NAUT	OVID	CHRS	CDXS	Ind. Median
Net Margin	—	-173.5%	—	-339.3%	-323.5%	-41.0%●	-125.7%
ROE	-42.7%	-37.0%	-33.7%	-18.8%●	—	-68.9%	-47.5%
ROA	-33.6%	-27.3%	-28.2%	-15.7%●	-47.6%	-24.8%	-35.8%
EBITDA Margin	—	-148.9%	—	-337.0%	-341.0%	-28.2%●	-105.8%

Growth + Dividend
Metric	IPSC	ARCT	NAUT	OVID	CHRS	CDXS	Ind. Median
Rev. Growth	-100.0%	-66.4%	-100.0%	1,199.6%●	-76.3%	56.8%	5.1%
NI Growth	—	—	—	—	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on IPSC

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.